Fusion genes in angiomatoid fibrous histiocytoma

被引:64
作者
Hallor, Karolin H. [1 ]
Micci, Francesca
Meis-Kindblom, Jeanne M.
Kindblom, Lars-Gunnar
Bacchini, Patrizia
Mandahl, Nils
Mertens, Fredrik
Panagopoulos, Ioannis
机构
[1] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden
[2] Norwegian Radium Hosp, Dept Med Genet, Oslo, Norway
[3] Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden
[4] Sahlgrens Univ Hosp, Lundberg Lab Canc Res, S-41345 Gothenburg, Sweden
[5] Royal Orthopaed Hosp, Dept Musculoskeletal Pathol, Birmingham B31 2AP, W Midlands, England
[6] Ist Ortoped, Dept Anat Pathol, Bologna, Italy
关键词
angiomatoid fibrous histiocytoma; clear cell sarcoma; EWSR1; ATF1; MITE; SOX10;
D O I
10.1016/j.canlet.2006.11.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor of low malignant potential and uncertain differentiation. Only three genetically investigated cases of AFH have been reported. Two of them displayed a FUS-ATF1 fusion gene and one showed an EWSR1-ATF1 chimera. Using RT-PCR analysis, we have identified the EWSR1-ATF1 fusion transcript, and delineated the genomic breakpoints, in two new cases of AFH. Previously, the EWSR1-ATF1 fusion protein has been suggested to activate expression of the MITF-M transcript, and therefore the expression pattern of the MITF gene was studied. The MITF-M transcript was not detected in either AFH, in line with the finding that the co-activator SOX10 was not expressed. Thus, of the five AFH that have been molecularly analyzed to date, two have displayed a FUS-ATF1 fusion gene and three have shown an EWSR1-ATF1 chimera. There is no apparent correlation between the type of fusion gene and clinicopathologic features. Nonetheless, RT-PCR for these fusion transcripts remains a valuable diagnostic adjunct in the distinction between AFH and other soft tissue tumors or metastases that may simulate it. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:158 / 163
页数:6
相关论文
共 21 条
[21]   Chromosome translocation based on illegitimate recombination in human tumors [J].
Zucman-Rossi, J ;
Legoix, P ;
Victor, JM ;
Lopez, B ;
Thomas, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11786-11791